Investors
Diagnostics companies are building the infrastructure precision medicine runs on. The product to launch, the channel to lead with, the indication to anchor a development pipeline, the category to enter next, the growth strategy when the core market matures — these are the decisions that determine where a Dx company wins, how it reaches its market, and which categories are worth building for.

Select Capabilities
Product Specification Mapping
Your product doesn’t need to be competitive today – it needs to be competitive in the years to come. We understand the constraints and tradeoffs that are required in product development, and how that impacts market opportunity. DeciBio has the qualitative and quantitative tools to ensure you develop the optimal product for your target customers.
Selected Work

PE-Backed Life Sciences Tools Platform Development
Voice-of-Customer Research
Customer Segmentation
Pricing Strategy
Due Diligence
Competitive Analysis

Investment Diligence into Leading Oncology Diagnostic Provider
Voice-of-Customer Research
Competitive Analysis
Revenue Projection
Due Diligence








.png)
.png)




